BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03897881-completion@plaintrial.com
DTSTAMP:20261027T233422Z
DTSTART;VALUE=DATE:20321130
SUMMARY:An Efficacy Study of Adjuvant Treatment With the Personalized Cance
 r Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melan
 oma (KEYNOTE-942) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03897881
URL:https://plaintrial.com/trial/NCT03897881
END:VEVENT
END:VCALENDAR